Boston Scientific Corporation ‘s BSX SYNERGY Bioabsorbable Polymer Drug Eluting Stent System (BP DES) recently won the U.S. Food and Drug Administration (FDA) approval for treating coronary artery disease (CAD) patients. Post approval, this medical device major will immediately